• Explore /
  • Poster
  • / A phase II trial of trastuzumab combined with irinotecan in patients with advanced HER2-positive chemo-refractory gastric cancer: OGSG1203 (HERBIS-5).

A phase II trial of trastuzumab combined with irinotecan in patients with advanced HER2-positive chemo-refractory gastric cancer: OGSG1203 (HERBIS-5).

Abstract Poster

Authors

null

Kazuhiro Nishikawa

Department of Surgery, Osaka National Hospital, Osaka, Japan

Kazuhiro Nishikawa , Daisuke Sakai , Junji Kawada , Ryohei Kawabata , Tomono Kawase , Yoshio Oka , Naotoshi Sugimoto , Takeshi Shimizu , Junichi Nishijima , Hiroko Hasegawa , Shunji Endo , Yutaka Isozaki , Yutaka Kimura , Jin Matsuyama , Yukinori Kurokawa , Toshio Shimokawa , Kazumasa Fujitani , Taroh Satoh

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2016 Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session A: Cancers of the Esophagus and Stomach

Track

Cancers of the Esophagus and Stomach

Sub Track

Multidisciplinary Treatment

Clinical Trial Registration Number

000008626

Citation

J Clin Oncol 34, 2016 (suppl 4S; abstr 128)

DOI

10.1200/jco.2016.34.4_suppl.128

Abstract #

128

Poster Bd #

L20

Abstract Disclosures

Similar Posters

First Author: Feng Wang

First Author: Katsunori Shinozaki

First Author: Yasuyuki Kawamoto

First Author: Tomono Kawase